Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

ClinicalTrials.gov ID: NCT04630808

Public ClinicalTrials.gov record NCT04630808. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this clinical study is to evaluate the safety and efficacy of NCX 470 Ophthalmic Solution in lowering intraocular pressure (IOP) in subjecs with ocular hypertension or open-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.

Study identification

NCT ID
NCT04630808
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nicox Ophthalmics, Inc.
Industry
Enrollment
696 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 84 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2020 (Actual)
Primary completion
Apr 11, 2025 (Actual)
Completion
Jun 25, 2025 (Actual)
Last update posted
Sep 8, 2025

2020 – 2025

United States locations

U.S. sites
63
U.S. states
24
U.S. cities
57
Facility City State ZIP Site status
Nicox Clinical Site Dothan Alabama 36301 —
Nicox Clinical Site Chandler Arizona 85224 —
Nicox Clinical Site Phoenix Arizona 85003 —
Nicox Clinical Site Burbank California 91505 —
Nicox Clinical Site Garden Grove California 92843 —
Nicox Clinical Site Huntington Beach California 92647 —
Nicox Clinical Site La Jolla California 92037 —
Nicox Clinical Site Murrieta California 92562 —
Nicox Clinical Site Newport Beach California 92663 —
Nicox Clinical Site Pasadena California 91107 —
Nicox Clinical Site Petaluma California 94954 —
Nicox Clinical Site Redlands California 92373 —
Nicox Clinical Site San Francisco California 94115 —
Nicox Clinical Site Danbury Connecticut 06810 —
Nicox Clinical Site Boynton Beach Florida 33437 —
Nicox Clinical Site Delray Beach Florida 33484 —
Nicox Clinical Site Fort Lauderdale Florida 33309 —
Nicox Clinical Site Fort Myers Florida 33901 —
Nicox Clinical Site Jacksonville Florida 32256 —
Nicox Clinical Site Jupiter Florida 33477 —
Nicox Clinical Site Lakeland Florida 33805 —
Nicox Clinical Site Largo Florida 33770 —
Nicox Clinical Site Mt. Dora Florida 32757 —
Nicox Clinical Site Venice Florida 34285 —
Nicox Clinical Site Morrow Georgia 30260 —
Nicox Clinical Site Roswell Georgia 30076 —
Nicox Clinical Site Peoria Illinois 61615 —
Nicox Clinical Site Rock Island Illinois 61201 —
Nicox Clinical Site Indianapolis Indiana 46202 —
Nicox Clinical Site Bangor Maine 04401 —
Nicox Clinical Site Boston Massachusetts 02114 —
Nicox Clinical Site Lancaster Massachusetts 01523 —
Nicox Clinical Site Grand Rapids Michigan 49546 —
Nicox Clinical Site Chaska Minnesota 55318 —
Nicox Clinical Site Kansas City Missouri 64111 —
Nicox Clinical Site St Louis Missouri 63128 —
Nicox Clinical Site Clifton Park New York 12065 —
Nicox Clinical Site The Bronx New York 10467 —
Nicox Clinical Site Troy New York 12180 —
Nicox Clinical Site Asheville North Carolina 28803 —
Nicox Clinical Site Winston-Salem North Carolina 27101 —
Nicox Clinical Site Fargo North Dakota 58103 —
Nicox Clinical Site Cincinnati Ohio 45236 —
Nicox Clinical Site Cincinnati Ohio 45242 —
Nicox Clinical Site Eugene Oregon 97401 —
Nicox Clinical Site Cranberry Township Pennsylvania 16066 —
Nicox Clinical Site Kingston Pennsylvania 18704 —
Nicox Clinical Site Memphis Tennessee 38119 —
Nicox Clinical Site Memphis Tennessee 38120 —
Nicox Clinical Site Austin Texas 78731 —
Nicox Clinical Site El Paso Texas 79922 —
Nicox Clinical Site Houston Texas 77008 —
Nicox Clinical Site Houston Texas 77025 —
Nicox Clinical Site Mission Texas 78572 —
Nicox Clinical Site San Antonio Texas 78212 —
Nicox Clinical Site San Antonio Texas 78229 —
Nicox Clinical Site San Antonio Texas 78238 —
Nicox Clinical Site Sugar Land Texas 77479 —
Nicox Clinical Site St. George Utah 84790 —
Nicox Clinical Site Falls Church Virginia 22042 —
Nicox Clinical Site Bellevue Washington 98004 —
Nicox Clinical Site Seattle Washington 98104 —
Nicox Clinical Site Seattle Washington 98125 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04630808, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 8, 2025 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04630808 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →